In the In Reply letter entitled “FDA Expanded Access Programs for Experimental Medicines” published in the September 22/29, 2015, issue of JAMA,1 the author affiliation for Mr Kuhlik is incorrect. The author affiliations should read, “Merck, Kenilworth, New Jersey (Rosenblatt); Formerly with Merck (Kuhlik).” This article was corrected online.
Clarification of Author Affiliation. JAMA. 2015;314(16):1753. doi:10.1001/jama.2015.12980